The company’s market is sunscreen producers and ANO said that communication from its US distributor suggested that manufacturing had restarted and it was anticipating a return to normal.

“We anticipate that the net profit before tax for full year 2020 will be approximately $8.4 million, 2.5 times greater than the FY19 profit before tax. This is on anticipated turnover of $18 million up 46 per cent on FY19, subject to no further adverse market conditions or delays in any further sales orders.

“We have established stockpiles in a central US logistics facility in order to take advantage of the expected upturn in market conditions.

“Due to the changes to the existing contractual arrangements, the board is now able to expand our aluminium oxide business into new markets and improve supply to our existing key customer by raising capacity, improving quality and making stock available at an EU based contract logistics facility.

“These developments should also allow ANO to maintain pricing into the foreseeable future or possibly offer volume rebates where needed. The positive impact on sales from these changes cannot be determined for some months.”

Sales for full-year 2020 for the aluminium oxide product were expected to be $2 million.

For chief executive Geoff Acton the business is personal. He recounts on the company’s website how he has had 31 skin cancer procedures since 2005.

The announcement comes at the end of a controversial period for the company, which made explosive claims against the ASX and debt collection company Collection House but later retracted them.